Will Molecular Optical Imaging Have Clinically Important Roles in Stroke Management, and How?

키워드

참고문헌 (88)

1. Lloyd-Jones D, "Heart disease and stroke statistics-2009 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee", Circulation, 119, pp.480~486 (2009)
2. Stoll G, "Inflammation and atherosclerosis:novel insights into plaque formation and destabilization", Stroke, 37, pp.1923~1932 (2006)
3. Libby P, "Inflammation in atherosclerosis", Nature, 420, pp.868~874 (2002)
4. Lusis AJ, "Atherosclerosis", Nature, 407, pp.233~241 (2000)
5. Aikawa M, "The vulnerable atherosclerotic plaque:pathogenesis and therapeutic approach", Cardiovasc Pathol, 13, pp.125~138 (2004)
6. Naghavi M, "From vulnerable plaque to vulnerable patient-Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report", Am J Cardiol, 98(2A), pp.2H~15H (2006)
7. Virmani R, "Lessons from sudden coronary death:a comprehensive morphological classification scheme for atherosclerotic lesions", Arterioscler Thromb Vasc Biol, 20, pp.1262~1275 (2000)
8. "Indications for fibrinolytic therapy in suspected acute myocardial infarction:collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients.Fibrinolytic Therapy Trialists’(FTT)Collaborative Group", Lancet, 343, pp.311~322 (1994)
9. 방오영, "Multimodal MRI for Ischemic Stroke: From Acute Therapy to Preventive Strategies", Journal of Clinical Neurology, 5(3), pp.107~119 (2009), 대한신경과학회
10. Brott T, "Treatment of acute ischemic stroke", N Engl J Med, 343, pp.710~722 (2000)
11. "Tissue plasminogen activator for acute ischemic stroke.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group", N Engl J Med, 333, pp.1581~1587 (1995)
12. "Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke.The NINDS t-PA Stroke Study Group", Stroke, 28, pp.2109~2118 (1997)
13. Molina CA, "Extending reperfusion therapy for acute ischemic stroke:emerging pharmacological,mechanical,and imaging strategies", Stroke, 36, pp.2311~2320 (2005)
14. Wang X, "Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke", Stroke, 35(11 Suppl 1), pp.2726~2730 (2004)
15. Cheng T, "Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage", Nat Med, 12, pp.1278~1285 (2006)
16. Rosell A, "Mechanisms and markers for hemorrhagic transformation after stroke", Acta Neurochir Suppl, 105, pp.173~178 (2008)
17. Diedler J, "Decompressive surgery for severe brain edema", J Intensive Care Med, 24, pp.168~178 (2009)
18. ):a multicentre,open,randomised trial, "Lancet Neurol", 2009, 326~333
19. Kohrmann M, "Hemicraniectomy for malignant middle cerebral artery infarction", Curr Opin Crit Care, 15, pp.125~130 (2009)
20. Adams HP Jr, "Guidelines for the early management of adults with ischemic stroke:a guideline from the American Heart Association", American Stroke Association Stroke Council,Clinical Cardiology Council,Cardiovascular Radiology and Intervention Council,and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups:the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists, 2007, pp.38, 1655~1711
21. Jaffer FA, "Molecular imaging in the clinical arena", JAMA, 293, pp.855~862 (2005)
22. Massoud TF, "Molecular imaging in living subjects:seeing fundamental biological processes in a new light", Genes Dev, 17, pp.545~580 (2003)
23. Wickline SA, "Nanotechnology for molecular imaging and targeted therapy", Circulation, 107, pp.1092~1095 (2003)
24. Fayad ZA, "Cardiovascular molecular imaging", Arterioscler Thromb Vasc Biol, 29, pp.981~982 (2009)
25. Tempany CM, "Advances in biomedical imaging", JAMA, 285, pp.562~567 (2001)
26. Weissleder R, "Molecular imaging", Radiology, 219, pp.316~333 (2001)
27. Sanz J, "Imaging of atherosclerotic cardiovascular disease", Nature, 451, pp.953~957 (2008)
28. Wong FC, "A review of molecular imaging studies reaching the clinical stage", Eur J Radiol, 70, pp.205~211 (2009)
29. Yang M, "Whole-body subcellular multicolor imaging of tumor-host interaction and drug response in real time", Cancer Res, 67, pp.5195~5200 (2007)
30. Choudhury RP, "Molecular imaging in atherosclerosis,thrombosis,and vascular inflammation", Arterioscler Thromb Vasc Biol, 29, pp.983~991 (2009)
31. Jaffer FA, "Optical and multimodality molecular imaging:insights into atherosclerosis", Arterioscler Thromb Vasc Biol, 29, pp.1017~1024 (2009)
32. Rudd JH, "Inflammation imaging in atherosclerosis", Arterioscler Thromb Vasc Biol, 29, pp.1009~1016 (2009)
33. Schwille P, "Molecular dynamics in living cells observed by fluorescence correlation spectroscopy with one-and two-photon excitation", Biophys J, 77, pp.2251~2265 (1999)
34. Weissleder R, "In vivo imaging of tumors with protease-activated near-infrared fluorescent probes", Nat Biotechnol, 17, pp.375~378 (1999)
35. Terai T, "Fluorescent probes for bioimaging applications", Curr Opin Chem Biol, 12, pp.515~521 (2008)
36. Ntziachristos V, "Looking and listening to light:the evolution of whole-body photonic imaging", Nat Biotechnol, 23, pp.313~320 (2005)
37. Weissleder R, "Shedding light onto live molecular targets", Nat Med, 9, pp.123~128 (2003)
38. Chang K, "Advances in fluorescence imaging of the cardiovascular system", J Nucl Cardiol, 15, pp.417~428 (2008)
39. Funovics MA, "Catheter-based in vivo imaging of enzyme activity and gene expression:feasibility study in mice", Radiology, 231, pp.659~666 (2004)
40. Feigin VL, "Stroke epidemiology:a review of population-based studies of incidence,prevalence,and case-fatality in the late 20th century", Lancet Neurol, 2, pp.43~53 (2003)
41. Barnett HJ, "Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.",North American Symptomatic Carotid Endarterectomy Trial Collaborators", N Engl J Med, 339, pp.1415~1425 (1998)
42. Burke AP, "Coronary risk factors and plaque morphology in men with coronary disease who died suddenly", N Engl J Med, 336, pp.1276~1282 (1997)
43. Crouse JR 3rd, "Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery", Circulation, 92, pp.1141~1147 (1995)
44. Virmani R, "Vulnerable plaque:the pathology of unstable coronary lesions", J Interv Cardiol, 15, pp.439~446 (2002)
45. U-King-Im JM, "Carotid-artery imaging in the diagnosis and management of patients at risk of stroke", Lancet Neurol, 8, pp.569~580 (2009)
46. Nighoghossian N, "The vulnerable carotid artery plaque:current imaging methods and new perspectives", Stroke, 36, pp.2764~2772 (2005)
47. Yuan C, "Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization", J Magn Reson Imaging, 15, pp.62~67 (2002)
48. Lindner JR, "Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes", Circulation, 102, pp.2745~2750 (2000)
49. Weinberger J, "A new noninvasive technique for imaging atherosclerotic plaque in the aortic arch of stroke patients by transcutaneous real-time B-mode ultrasonography:an initial report", Stroke, 29, pp.673~676 (1998)
50. Inzitari D, "The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis.North American Symptomatic Carotid Endarterectomy Trial Collaborators", N Engl J Med, 342, pp.1693~1700 (2000)
51. Lanzino G, "Treatment of carotid artery stenosis: medical therapy, surgery, or stenting?", Mayo Clin Proc, 84, pp.362~368 (2009)
52. Usman AA, "Metaanalysis of procedural stroke and death among octogenarians:carotid stenting versus carotid endarterectomy", J Am Coll Surg, 208, pp.1124~1131 (2009)
53. Rerkasem K, "Temporal trends in the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis:an updated systematic review", Eur J Vasc Endovasc Surg, 37, pp.504~511 (2009)
54. Virmani R, "Pathology of the vulnerable plaque", J Am Coll Cardiol, 47(8 Suppl), pp.C13~C18 (2006)
55. Papaspyridonos M, "Novel candidate genes in unstable areas of human atherosclerotic plaques", Arterioscler Thromb Vasc Biol, 26, pp.1837~1844 (2006)
56. Lee S, "A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination", Angew Chem Int Ed Engl, 47, pp.2804~2807 (2008)
57. Jaffer FA, "Molecular imaging of cardiovascular disease", Circulation, 116, pp.1052~1061 (2007)
58. Deguchi JO, "Inflammation in atherosclerosis:visualizing matrix metalloproteinase action in macrophages in vivo", Circulation, 114, pp.55~62 (2006)
59. Chen J, "In vivo imaging of proteolytic activity in atherosclerosis", Circulation, 105, pp.2766~2771 (2002)
60. Aikawa E, "Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease", Circulation, 115, pp.377~386 (2007)
61. Kim DE, "Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine", Mol Imaging, 8, pp.291~301 (2009)
62. Jaffer FA, "Optical visualization of cathepsin K activity in atherosclerosis with a novel,protease-activatable fluorescence sensor", Circulation, 115, pp.2292~2298 (2007)
63. Sarai M, "Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging", J Am Coll Cardiol, 50, pp.2305~2312 (2007)
64. Kietselaer BL, "Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis", N Engl J Med, 350, pp.1472~1473 (2004)
65. Winter PM, "Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles", Circulation, 108, pp.2270~2274 (2003)
66. Trivedi RA, "Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages", rterioscler Thromb Vasc Biol, c26, pp.1601~1606 (2006)
67. Nahrendorf M, "Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis", Circulation, 117, pp.379~387 (2008)
68. Hyafil F, "Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography", Nat Med, 13, pp.636~641 (2007)
69. Kim DE, "Neural stem cell transplant survival in brains of mice:assessing the effect of immunity and ischemia by using real-time bioluminescent imaging", Radiology, 241, pp.822~830 (2006)
70. Kim DE, "Nearinfrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis", J Cereb Blood Flow Metab, 25, pp.226~233 (2005)
71. Jaffer FA, "Molecular imaging of factor XIIIa activity in thrombosis using a novel,near-infrared fluorescent contrast agent that covalently links to thrombi", Circulation, 110, pp.170~176 (2004)
72. Muszbek L, "Blood coagulation factor XIII:structure and function", Thromb Res, 94, pp.271~305 (1999)
73. Robinson BR, "Catalytic life of activated factor XIII in thrombi.Implications for fibrinolytic resistance and thrombus aging", Circulation, 102, pp.1151~1157 (2000)
74. Zhu Y, "Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance", Circulation, 99, pp.3050~3055 (1999)
75. Stassen JM, "The hemostatic system", Curr Med Chem, 11, pp.2245~2260 (2004)
76. Woitzik J, "Cortical perfusion measurement by indocyanine-green videoangiography in patients undergoing hemicraniectomy for malignant stroke", Stroke, 37, pp.1549~1551 (2006)
77. Coutinho JM, "Decompressive hemicraniectomy in cerebral sinus thrombosis:consecutive case series and review of the literature", Stroke, 40, pp.2233~2235 (2009)
78. Owens SL, "Indocyanine green angiography", Br J Ophthalmol, 80, pp.263~266 (1996)
79. Czabanka M, "Characterization of cortical microvascularization in adult moyamoya disease", Stroke, 39, pp.1703~1709 (2008)
80. Pestalozza IF, "Ischaemic penumbra:highlights", Clin Exp Hypertens, 24, pp.517~529 (2002)
81. Lo EH, "A new penumbra:transitioning from injury into repair after stroke", Nat Med, 14, pp.497~500 (2008)
82. Dirnagl U, "Pathobiology of ischaemic stroke:an integrated view", Trends Neurosci, 22, pp.391~397 (1999)
83. Urano Y, "Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes", Nat Med, 15, pp.104~109 (2009)
84. Kircher MF, "A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation", Cancer Res, 63, pp.8122~8125 (2003)
85. Choi Y, "Selective antitumor effect of novel protease-mediated photodynamic agent", Cancer Res, 66, pp.7225~7229 (2006)
86. Kim DE, "Protease Imaging of Human Atheromata Captures Molecular Information of Atherosclerosis,Complementing Anatomic Imaging", Arterioscler Thromb Vasc Biol, 30, pp.449~456 (2010)
87. 김동억, "동맥경화 분자영상", 대한의사협회지, 52(2), pp.143~150 (2009), 대한의사협회
88. 김동억, "동맥경화 병태생리 및 치료 효과를 탐지하는 Cathepsin-B 단백분해효소 활성도 광학 분자영상", 대한신경과학회지, 27(1), pp.36~41 (2009), 대한신경과학회

관련 논문AI추천